AbelsonTaylor has promoted Laura Paul to senior account director, where she’ll spearhead the launch of a new treatment for recurrent C-difficile in microbiome therapeutics. Paul has worked at AbelsonTaylor since 2011, where she’s helped develop campaigns across a variety of therapeutic areas. Previously, she served as account supervisor for Corbett Accel Healthcare Group (now TBWA WorldHealth).
“Laura has contributed significantly to the success of the agency and our clients through her management skills, broad experience, and strong strategic sense,” Eric Densmore, senior vice president, said in a statement. “With expanded leadership responsibilities, she is positioned to make even greater contributions.”